Clinical Presentations

How MyoStrain® CMR May Help Cancer Patients – Focus on T1 and T2 Mapping

April 15, 2020
European Society of Cardiology Congress 2020
Presented by
Assoc. Prof. Dr. Valentina Püntmann, MD, PhD, FRCP
Consultant Cardiologist, Institute for Experimental and Translational Cardiovascular Imaging
Department of Cardiology, Division of Internal Medicine
University Hospital Frankfurt, Germany

This cardio-oncology webinar discusses the role of advanced MyoStrain CMR during the cancer care process, helping to bridge the clinical gap between cardiologists and oncologists. Topics include the use of MyoStrain to help clinicians prevent cardiotoxicity associated with cancer therapy, how to perform an early diagnosis of subclinical left ventricular dysfunction and how this information can be use to help guide clinical decision-making.

See original content